
Jane J. Zara
Examiner (ID: 18595)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1674, 1637, 1635 |
| Total Applications | 1842 |
| Issued Applications | 1032 |
| Pending Applications | 285 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6825593
[patent_doc_number] => 20030236215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells'
[patent_app_type] => new
[patent_app_number] => 10/456573
[patent_app_country] => US
[patent_app_date] => 2003-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 28827
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236215.pdf
[firstpage_image] =>[orig_patent_app_number] => 10456573
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/456573 | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells | Jun 8, 2003 | Abandoned |
Array
(
[id] => 7148057
[patent_doc_number] => 20040170613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Compositions and methods for liver growth and liver protection'
[patent_app_type] => new
[patent_app_number] => 10/455470
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23754
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170613.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455470
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455470 | Compositions and methods for liver growth and liver protection | Jun 4, 2003 | Issued |
Array
(
[id] => 7314266
[patent_doc_number] => 20040033977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Oligonucleotide modulation of cell adhesion'
[patent_app_type] => new
[patent_app_number] => 10/454663
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 27619
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10454663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/454663 | Oligonucleotide modulation of cell adhesion | Jun 3, 2003 | Abandoned |
Array
(
[id] => 823721
[patent_doc_number] => 07405205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-29
[patent_title] => 'Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase'
[patent_app_type] => utility
[patent_app_number] => 10/447136
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 29054
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/405/07405205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10447136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/447136 | Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase | May 28, 2003 | Issued |
Array
(
[id] => 6806283
[patent_doc_number] => 20030233677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Modification of fatty acid metabolism in plants'
[patent_app_type] => new
[patent_app_number] => 10/447515
[patent_app_country] => US
[patent_app_date] => 2003-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16209
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20030233677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10447515
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/447515 | Modification of fatty acid metabolism in plants | May 27, 2003 | Abandoned |
Array
(
[id] => 830033
[patent_doc_number] => 07399586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-15
[patent_title] => 'Modulation of biological signal transduction by RNA interference'
[patent_app_type] => utility
[patent_app_number] => 10/444795
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 48
[patent_no_of_words] => 41857
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/399/07399586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444795 | Modulation of biological signal transduction by RNA interference | May 22, 2003 | Issued |
Array
(
[id] => 4451390
[patent_doc_number] => 07964714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'Gene expression suppression agents'
[patent_app_type] => utility
[patent_app_number] => 10/552909
[patent_app_country] => US
[patent_app_date] => 2003-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 2766
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964714.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552909
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552909 | Gene expression suppression agents | May 11, 2003 | Issued |
Array
(
[id] => 7439754
[patent_doc_number] => 20040009152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Materials and methods for prevention and treatment of RNA viral diseases'
[patent_app_type] => new
[patent_app_number] => 10/426436
[patent_app_country] => US
[patent_app_date] => 2003-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 21844
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009152.pdf
[firstpage_image] =>[orig_patent_app_number] => 10426436
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/426436 | Materials and methods for prevention and treatment of RNA viral diseases | Apr 29, 2003 | Issued |
Array
(
[id] => 7445497
[patent_doc_number] => 20040009591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Keratinocytes expressing exogenous angiogenic growth factors'
[patent_app_type] => new
[patent_app_number] => 10/425784
[patent_app_country] => US
[patent_app_date] => 2003-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 20363
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009591.pdf
[firstpage_image] =>[orig_patent_app_number] => 10425784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/425784 | Keratinocytes expressing exogenous angiogenic growth factors | Apr 28, 2003 | Issued |
Array
(
[id] => 7033544
[patent_doc_number] => 20050032053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Nucleic acid molecules with reduced secondary structure'
[patent_app_type] => utility
[patent_app_number] => 10/423199
[patent_app_country] => US
[patent_app_date] => 2003-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 12682
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032053.pdf
[firstpage_image] =>[orig_patent_app_number] => 10423199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/423199 | Nucleic acid molecules with reduced secondary structure | Apr 24, 2003 | Abandoned |
Array
(
[id] => 7310404
[patent_doc_number] => 20040142884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Compositions and methods for the acceleration of protein secretion dynamics'
[patent_app_type] => new
[patent_app_number] => 10/419539
[patent_app_country] => US
[patent_app_date] => 2003-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17886
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10419539
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/419539 | Compositions and methods for the acceleration of protein secretion dynamics | Apr 20, 2003 | Issued |
Array
(
[id] => 274065
[patent_doc_number] => 07560229
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-14
[patent_title] => 'Methods of use of the enzymes of mycothiol synthesis'
[patent_app_type] => utility
[patent_app_number] => 10/511244
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 37159
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/560/07560229.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511244 | Methods of use of the enzymes of mycothiol synthesis | Apr 14, 2003 | Issued |
Array
(
[id] => 682439
[patent_doc_number] => 07081363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-25
[patent_title] => 'Better emergence characteristics and improved seedling growth under low-light environments'
[patent_app_type] => utility
[patent_app_number] => 10/386499
[patent_app_country] => US
[patent_app_date] => 2003-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23997
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/081/07081363.pdf
[firstpage_image] =>[orig_patent_app_number] => 10386499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/386499 | Better emergence characteristics and improved seedling growth under low-light environments | Mar 12, 2003 | Issued |
Array
(
[id] => 7107981
[patent_doc_number] => 20050205434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Dna conformational switches as sensitive electronic sensors of analytes'
[patent_app_type] => utility
[patent_app_number] => 10/507387
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12874
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20050205434.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507387 | DNA conformational switches as sensitive electronic sensors of analytes | Mar 10, 2003 | Issued |
Array
(
[id] => 849190
[patent_doc_number] => 07381708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-03
[patent_title] => 'Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye'
[patent_app_type] => utility
[patent_app_number] => 10/383614
[patent_app_country] => US
[patent_app_date] => 2003-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 73
[patent_no_of_words] => 29474
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/381/07381708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10383614
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/383614 | Suppression of eIF5A1 expression by the use of antisense oligonucleotides for the prevention of retinal cell death in the glaucomatous eye | Mar 9, 2003 | Issued |
Array
(
[id] => 4574517
[patent_doc_number] => 07829693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-09
[patent_title] => 'Compositions and methods for inhibiting expression of a target gene'
[patent_app_type] => utility
[patent_app_number] => 10/384339
[patent_app_country] => US
[patent_app_date] => 2003-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 30
[patent_no_of_words] => 16999
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/829/07829693.pdf
[firstpage_image] =>[orig_patent_app_number] => 10384339
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/384339 | Compositions and methods for inhibiting expression of a target gene | Mar 6, 2003 | Issued |
Array
(
[id] => 5748380
[patent_doc_number] => 20060111312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Antigene locks and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/505308
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27643
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111312.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505308
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505308 | Antigene locks and therapeutic uses thereof | Feb 23, 2003 | Abandoned |
Array
(
[id] => 6912250
[patent_doc_number] => 20050176008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Polynucleotide for target gene'
[patent_app_type] => utility
[patent_app_number] => 10/505153
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19027
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505153 | Polynucleotide for target gene | Feb 20, 2003 | Abandoned |
Array
(
[id] => 6821250
[patent_doc_number] => 20030219411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Modulators of the function of FAS receptors and other proteins'
[patent_app_type] => new
[patent_app_number] => 10/368438
[patent_app_country] => US
[patent_app_date] => 2003-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 34183
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10368438
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/368438 | Modulators of the function of FAS receptors and other proteins | Feb 19, 2003 | Abandoned |
Array
(
[id] => 7397430
[patent_doc_number] => 20040018508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Surrogate antibodies and methods of preparation and use thereof'
[patent_app_type] => new
[patent_app_number] => 10/370052
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 41061
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018508.pdf
[firstpage_image] =>[orig_patent_app_number] => 10370052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/370052 | Surrogate antibodies and methods of preparation and use thereof | Feb 18, 2003 | Abandoned |